BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 22852281)

  • 21. Does Sildenafil produce a sustained benefit in patients with pulmonary hypertension associated with parenchymal lung and cardiac disease?
    Madden BP; Sheth A; Wilde M; Ong YE
    Vascul Pharmacol; 2007; 47(2-3):184-8. PubMed ID: 17627899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic potential of sildenafil in patients with heart failure and reactive pulmonary hypertension.
    Dumitrescu D; Seck C; Möhle L; Erdmann E; Rosenkranz S
    Int J Cardiol; 2012 Jan; 154(2):205-6. PubMed ID: 22104986
    [No Abstract]   [Full Text] [Related]  

  • 23. Sildenafil citrate for the prevention of high altitude hypoxic pulmonary hypertension: double blind, randomized, placebo-controlled trial.
    Bates MG; Thompson AA; Baillie JK; Sutherland AI; Irving JB; Hirani N; Webb DJ
    High Alt Med Biol; 2011; 12(3):207-14. PubMed ID: 21962063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical use of sildenafil in pulmonary artery hypertension.
    Singh TP
    Expert Rev Respir Med; 2010 Feb; 4(1):13-9. PubMed ID: 20387288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Sildenafil in pulmonary hypertension: the opinion of pediatric cardiologist].
    Micheletti A; Butera G; Chessa M; Carminati M
    Pediatr Med Chir; 2008; 30(3):159-62. PubMed ID: 19024861
    [No Abstract]   [Full Text] [Related]  

  • 26. Sildenafil: a review of its use in pulmonary arterial hypertension.
    Croom KF; Curran MP
    Drugs; 2008; 68(3):383-97. PubMed ID: 18257613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Selective vasodilation in the lung. Sildenafil improves physical capacity and prognosis].
    MMW Fortschr Med; 2007 May; 149(22):45. PubMed ID: 18069228
    [No Abstract]   [Full Text] [Related]  

  • 28. Therapeutic applications of sildenafil citrate in the management of paediatric pulmonary hypertension.
    Leibovitch L; Matok I; Paret G
    Drugs; 2007; 67(1):57-73. PubMed ID: 17209664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute and long-term efficacy and safety of sildenafil for the treatment of chronic thromboembolic pulmonary hypertension in a heart transplant recipient.
    Zacà V; Padeletti M; Pagliaro A; Furiozzi F; Mondillo S; Favilli R
    Pharmacology; 2011; 87(1-2):24-7. PubMed ID: 21178386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Lacunar stroke after sildenafil administration].
    Arboix A; Alsina M; Massons J
    Med Clin (Barc); 2007 Mar; 128(10):398-9. PubMed ID: 17386250
    [No Abstract]   [Full Text] [Related]  

  • 31. Central retinal vein occlusion in a patient after being commenced on sildenafil citrate for pulmonary arterial hypertension.
    Pinto LM; Morekar S; Mahashur AA
    Indian J Chest Dis Allied Sci; 2009; 51(4):249-51. PubMed ID: 20073379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sildenafil before total cavopulmonary connection.
    Naranjo-Ugalde AM; Rivera-Ladino KM; Consuegra-Chuarey MT; Marcano-Sanz LE; Palenzuela Lopez H
    Rev Esp Cardiol (Engl Ed); 2013 Jan; 66(1):71. PubMed ID: 22871348
    [No Abstract]   [Full Text] [Related]  

  • 33. The use of sildenafil to treat pulmonary hypertension associated with interstitial lung disease.
    Corte TJ; Gatzoulis MA; Parfitt L; Harries C; Wells AU; Wort SJ
    Respirology; 2010 Nov; 15(8):1226-32. PubMed ID: 20920139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Primary arterial pulmonary hypertension and sildenafil: a case report from Dakar].
    Bouldouyre M; Dia D; Ba FK; Diop IB; Debonne JM
    Dakar Med; 2006; 51(2):78-80. PubMed ID: 17632981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intrapulmonary shunting associated with sildenafil treatment in a patient with idiopathic pulmonary arterial hypertension.
    Castro PF; Greig D; Verdejo HE; Godoy I; Córdova S; Ferrada MP; Bourge RC
    Thorax; 2011 Dec; 66(12):1097-8. PubMed ID: 21289023
    [No Abstract]   [Full Text] [Related]  

  • 36. Phosphodiesterase type 5 inhibitors for pulmonary arterial hypertension.
    Archer SL; Michelakis ED
    N Engl J Med; 2009 Nov; 361(19):1864-71. PubMed ID: 19890129
    [No Abstract]   [Full Text] [Related]  

  • 37. [Sildenafil in neonate pulmonary hypertension: the opinion of neonatology physician].
    Condò V; Colnaghi MR; Mosca E
    Pediatr Med Chir; 2008; 30(3):156-8. PubMed ID: 19024860
    [No Abstract]   [Full Text] [Related]  

  • 38. [Efficacy and safety of sildenafil in the treatment of high altitude heart disease associated with severe pulmonary arterial hypertension in children: a preliminary evaluation].
    Xia YL; Yan WX; Chen H
    Zhongguo Dang Dai Er Ke Za Zhi; 2014 Jul; 16(7):745-8. PubMed ID: 25008885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sildenafil in idiopathic pulmonary fibrosis.
    Maher TM
    N Engl J Med; 2010 Nov; 363(22):2169; author reply 2170-1. PubMed ID: 21105804
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical characteristics and outcome of 13 dogs with pulmonary arterial hypertension (PH) treated with sildenafil.
    Moreno HJ
    J Vet Intern Med; 2007; 21(6):1165. PubMed ID: 18196719
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.